BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37646869)

  • 21. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
    Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
    Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
    Ondrejka SL; Amador C; Climent F; Ng SB; Soma L; Zamo A; Dirnhofer S; Quintanilla-Martinez L; Wotherspoon A; Leoncini L; de Leval L
    Virchows Arch; 2023 Sep; 483(3):349-365. PubMed ID: 37500795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
    Kataoka K; Miyoshi H; Sakata S; Dobashi A; Couronné L; Kogure Y; Sato Y; Nishida K; Gion Y; Shiraishi Y; Tanaka H; Chiba K; Watatani Y; Kakiuchi N; Shiozawa Y; Yoshizato T; Yoshida K; Makishima H; Sanada M; Onozawa M; Teshima T; Yoshiki Y; Ishida T; Suzuki K; Shimada K; Tomita A; Kato M; Ota Y; Izutsu K; Demachi-Okamura A; Akatsuka Y; Miyano S; Yoshino T; Gaulard P; Hermine O; Takeuchi K; Ohshima K; Ogawa S
    Leukemia; 2019 Jul; 33(7):1687-1699. PubMed ID: 30683910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms underlying transformation of large granular lymphocytic leukemia to high-grade T-cell lymphoma.
    Pastoret C; Llamas-Gutierrez F; Fouchard M; Moignet A; Boulland ML; Gaulard P; Houot R; Roussel M; Fest T; Lamy T; Marchand T
    Leukemia; 2023 Jul; 37(7):1567-1571. PubMed ID: 37142662
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature.
    Morille J; Mandon M; Rodriguez S; Roulois D; Leonard S; Garcia A; Wiertlewski S; Le Page E; Berthelot L; Nicot A; Mathé C; Lejeune F; Tarte K; Delaloy C; Amé P; Laplaud D; Michel L
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
    Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How I Diagnose EBV-Positive B- and T-Cell Lymphoproliferative Disorders.
    Dojcinov SD; Quintanilla-Martinez L
    Am J Clin Pathol; 2023 Jan; 159(1):14-33. PubMed ID: 36214507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
    Alaggio R; Amador C; Anagnostopoulos I; Attygalle AD; Araujo IBO; Berti E; Bhagat G; Borges AM; Boyer D; Calaminici M; Chadburn A; Chan JKC; Cheuk W; Chng WJ; Choi JK; Chuang SS; Coupland SE; Czader M; Dave SS; de Jong D; Du MQ; Elenitoba-Johnson KS; Ferry J; Geyer J; Gratzinger D; Guitart J; Gujral S; Harris M; Harrison CJ; Hartmann S; Hochhaus A; Jansen PM; Karube K; Kempf W; Khoury J; Kimura H; Klapper W; Kovach AE; Kumar S; Lazar AJ; Lazzi S; Leoncini L; Leung N; Leventaki V; Li XQ; Lim MS; Liu WP; Louissaint A; Marcogliese A; Medeiros LJ; Michal M; Miranda RN; Mitteldorf C; Montes-Moreno S; Morice W; Nardi V; Naresh KN; Natkunam Y; Ng SB; Oschlies I; Ott G; Parrens M; Pulitzer M; Rajkumar SV; Rawstron AC; Rech K; Rosenwald A; Said J; Sarkozy C; Sayed S; Saygin C; Schuh A; Sewell W; Siebert R; Sohani AR; Tooze R; Traverse-Glehen A; Vega F; Vergier B; Wechalekar AD; Wood B; Xerri L; Xiao W
    Leukemia; 2022 Jul; 36(7):1720-1748. PubMed ID: 35732829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
    Campo E; Jaffe ES; Cook JR; Quintanilla-Martinez L; Swerdlow SH; Anderson KC; Brousset P; Cerroni L; de Leval L; Dirnhofer S; Dogan A; Feldman AL; Fend F; Friedberg JW; Gaulard P; Ghia P; Horwitz SM; King RL; Salles G; San-Miguel J; Seymour JF; Treon SP; Vose JM; Zucca E; Advani R; Ansell S; Au WY; Barrionuevo C; Bergsagel L; Chan WC; Cohen JI; d'Amore F; Davies A; Falini B; Ghobrial IM; Goodlad JR; Gribben JG; Hsi ED; Kahl BS; Kim WS; Kumar S; LaCasce AS; Laurent C; Lenz G; Leonard JP; Link MP; Lopez-Guillermo A; Mateos MV; Macintyre E; Melnick AM; Morschhauser F; Nakamura S; Narbaitz M; Pavlovsky A; Pileri SA; Piris M; Pro B; Rajkumar V; Rosen ST; Sander B; Sehn L; Shipp MA; Smith SM; Staudt LM; Thieblemont C; Tousseyn T; Wilson WH; Yoshino T; Zinzani PL; Dreyling M; Scott DW; Winter JN; Zelenetz AD
    Blood; 2022 Sep; 140(11):1229-1253. PubMed ID: 35653592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
    Herek TA; Bouska A; Lone W; Sharma S; Amador C; Heavican TB; Li Y; Wei Q; Jochum D; Greiner TC; Smith L; Pileri S; Feldman AL; Rosenwald A; Ott G; Lim ST; Ong CK; Song J; Jaffe ES; Wang GG; Staudt L; Rimsza LM; Vose J; d'Amore F; Weisenburger DD; Chan WC; Iqbal J
    Blood; 2022 Sep; 140(11):1278-1290. PubMed ID: 35639959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
    Nicolae A; Bouilly J; Lara D; Fataccioli V; Lemonnier F; Drieux F; Parrens M; Robe C; Poullot E; Bisig B; Bossard C; Letourneau A; Missiaglia E; Bonnet C; Szablewski V; Traverse-Glehen A; Delfau-Larue MH; de Leval L; Gaulard P
    Mod Pathol; 2022 Aug; 35(8):1126-1136. PubMed ID: 35301414
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.